News and Announcements

Castle Point Ranger Fund: +2.21% (vs. perf hurdle +0.67%) in September 2014

Published October 07, 2014 11:44AM UTC
Publisher Wholesale Investor
Categories Company Updates

Dear Investors,The latest Ranger Fund monthly Fact Sheet is now available. Please click here to view or alternatively paste this link into your browser – www.castlepointfunds.com/documents.During the month of September the Ranger Fund benefited from positive performance by Paperlinx, Vista Group International, Boom Logistics, Swick Mining and Tower. The performance of the Fund was hindered by positions in A2 Milk Company and Corporate Travel Management.

Should you wish to discuss or clarify any aspect of fund performance or positioning, please feel free to contact us (on [email protected] or 09 300 6060).

Kind regards

The Castle Point Team

E: [email protected]
W: www.castlepointfunds.com
Level 4, 29-33 Shortland Street, Auckland1143, New Zealand

Company Updates

View All

Capital Insights

Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026

Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]

Capital Insights

The control layer for the electrified home

THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]

Capital Insights

500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market

In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]

View All